ClinicalTrials.Veeva

Menu

Effects of Chronic Acid-Base Changes on Ventilatory and Perceptual Responses

Q

Queen's University

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: NH4Cl (ammonium chloride)
Dietary Supplement: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00946933
DSS-16198

Details and patient eligibility

About

Approximately 30% of people aged 65 years and older experience breathlessness (perceived respiratory difficulty) during daily activity. The main causes of increased breathlessness in the healthy elderly are poorly understood and are the main focus of the proposed study. Some possible contributing factors include abnormalities in the control and/or mechanics of breathing. To evaluate these possible contributory factors, the investigators will compare ventilatory and perceptual responses to: 1) exercise, 2) increased levels of inspired carbon dioxide, and 3) reduced levels of inspired oxygen under strictly-controlled experimental conditions where the investigators increase or decrease breathing requirements by altering dietary salt intake in healthy 40-80 year old men and women.

Exercise and rebreathing tests will be performed at baseline and at the end of each 3 day treatment period. Breathlessness intensity will be measured and compared at a standardized work rate, ventilation or end-tidal PCO2 during these tests.

Enrollment

20 patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy, regularly active adults
  • non-smoking
  • BMI 18-30 kg/m2

Exclusion criteria

  • history of lung and/or heart disease (including cardiac arrhythmias) or other comorbidity which could interfere with proper conduct of the intervention or tests
  • hypotension or hypertension
  • hypercholesterolemia
  • sleep disordered breathing
  • inability to perform cycle exercise or comply with other testing procedures

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

20 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
0.025 g/kg/day of NaCl (sodium chloride)
Treatment:
Dietary Supplement: placebo
High salt diet
Active Comparator group
Description:
0.2 g/kg/day of NH4Cl (ammonium chloride)
Treatment:
Dietary Supplement: NH4Cl (ammonium chloride)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems